Submission Details
| 510(k) Number | K050371 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | February 14, 2005 |
| Decision Date | June 07, 2005 |
| Days to Decision | 113 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
K050371 is an FDA 510(k) clearance for the MEDRAD VANGUARD DX ANGIOGRAPHIC CATHETER, a Catheter, Intravascular, Diagnostic (Class II — Special Controls, product code DQO), submitted by Medrad, Inc. (Indianola, US). The FDA issued a Cleared decision on June 7, 2005, 113 days after receiving the submission on February 14, 2005. This device falls under the Cardiovascular review panel. Regulated under 21 CFR 870.1200.
| 510(k) Number | K050371 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | February 14, 2005 |
| Decision Date | June 07, 2005 |
| Days to Decision | 113 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
| Product Code | DQO — Catheter, Intravascular, Diagnostic |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 870.1200 |